ExLibris header image
SFX Logo
Title: HIV vaccine trials
Source:

Science [0036-8075] Vanischseni, S yr:1998


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. "Immunology: HIV vaccine success secrets." Nature 507.7493: 403-403. Link to SFX for this item
2. Girard, Marc P P. "A review of vaccine research and development: the human immunodeficiency virus (HIV)." Vaccine 24.19 (2006): 4062-81. Link to SFX for this item
3. Douek, Daniel C C. "The rational design of an AIDS vaccine." Cell 124.4 (2006): 677-81. Link to SFX for this item
4. Willyard, C. "Tiny steps towards an HIV vaccine." Nature 466.7304 (2010). Link to Full Text for this item Link to SFX for this item
5. Li, F. "Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation." Vaccine 24.47-48 (2006): 6893-904. Link to SFX for this item
6. Korber, B. "Converging on an HIV Vaccine." Science 333.6049 (2011): 1589-1590. Link to SFX for this item
7. Kwok, R. "The Real Issues in Vaccine Safety." Nature 473.7348 (2011): 436-438. Link to Full Text for this item Link to SFX for this item
8. Hankins, Catherine A. "Modeling the impact of RV144-like vaccines on HIV transmission." Vaccine 29.36 (2011): 6069-6071. Link to SFX for this item
9. Dahirel, V. "Coordinate linkage of HIV evolution reveals regions of immunological vulnerability." Proceedings of the National Academy of Sciences of the United States of America 108.28 (2011): 11530-11535. Link to Full Text for this item Link to SFX for this item
10. Wyatt, R. "The antigenic structure of the HIV gp120 envelope glycoprotein." Nature 393.6686 (1998): 705-11. Link to Full Text for this item Link to SFX for this item
11. Wyatt, Richard T T. "HIV vaccine design and the neutralizing antibody problem." Nature immunology 5.3 (2004): 233-6. Link to Full Text for this item Link to SFX for this item
12. Pantophlet, R. "GP120: Target for Neutralizing HIV-1 Antibodies." Annual review of immunology 24.1: 739-769. Link to SFX for this item
13. Hendrickson, Peter D. "Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody." Nature 393.6686 (1998): 648-59. Link to Full Text for this item Link to SFX for this item
14. Huang, Peter D C. "Structure of a V3-containing HIV-1 gp120 core." Science 310.5750 (2005): 1025-1028. Link to SFX for this item
15. Moore, J P P. "HIV - Envelope's letters boxed into shape." Nature 393.6686 (1998): 630-631. Link to Full Text for this item Link to SFX for this item
16. Wyatt, R. "The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens." Science 280.5371 (1998): 1884-8. Link to SFX for this item
17. McMichael, A. "HIV VACCINES." Annual review of immunology 24.1 (2006): 227-255. Link to Full Text for this item Link to SFX for this item
18. Burton, Robin R. "AIDS/HIV. A boost for HIV vaccine design." Science 329.5993 (2010): 770-3. Link to SFX for this item
19. Andersen, M H H. "The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients." Leukemia 19.3 (2005): 484-5. Link to Full Text for this item Link to SFX for this item
20. Cohen, J. "Novel Antibody Response May Explain HIV Vaccine Success." Science 333.6049 (2011): 1560-1560. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.